Influence of lipid concentration on encapsulation and particle size in the development of liposomal irinotecan
DOI:
https://doi.org/10.14739/2409-2932.2017.1.93448Keywords:
liposomes, irinotecan, lipid bilayers, phosphatidylcholine, cholesterol, high pressure homogenizationAbstract
Purpose. For creation of liposomal irinotecan form, the influence of lipid concentration on the encapsulation of the active substance and nanoparticle size was necessary to investigate.
Materials and methods. We used «chemical gradient" method for liposomes formulation, in the variety of “pH gradient”. Ammonium citrate at pH 2.5 was used as internal buffer. Lipid film was obtained, by evaporation technics with further high pressure homogenization with Microfluidics Microfluidizer M-110P apparatus. “Chemical gradient” was created by ultrafiltration, with “Minim 2” apparatus. Ultrafiltration cartridge with an upper cut-off 30 kDa was used. Encapsulation was measured using HPLC methods developed in variant of gel chromatography, with Shimadzu LC-20 instrument. The particle size was measured by laser diffraction method withe “Zetasizer Nano ZS” instrument.
Results. For the preparation of liposomes was applied a constant lipid ratio with varying of total lipid concentration. The ratio of lipids in the experiment was a phosphatidylcholine / cholesterol 80/20 % by weight. A total concentration was investigated in range from 10 mg/ml to 30 mg/ml. The number of extrusion cycles consisted from 3 cycles at 1500 bar, in case of 10 mg/ml concentration, to 17 cycles at 1500 bar, in case of 30 mg/ml concentration.
Conclusions. It was shown that the lipid concentration from 25 mg/ml led to particles formation with size more than 5000 nm, and it was not possible to reduce them by high pressure homogenization method. It was proven that the most optimal, in terms of technology and the final characteristics of liposomes, was lipids in concentration 20 mg/ml. The degree of encapsulation in this case was 82 ± 0.98 %. The size of the liposomes was 106 nm, 5000 nm particles were absent.
References
Frenzel, M., & Steffen-Heins, A. (2015) Impact of quercetin and fish oil encapsulation on bilayer membrane and oxidation stability of liposomes. Food Chemistry, 185, 48–57. doi: 10.1016/j.foodchem.2015.03.121.
Liau, J. J., Hook, S., Prestidge, C. A., & Barnes, T. J. (2015) A lipid based multi-compartmental system: Liposomes-in-double emulsion for oral vaccine delivery. European Journal of Pharmaceutics and Biopharmaceutics, 97, 15–21. doi: 10.1016/j.ejpb.2015.09.018.
Rizzitelli, S., Giustetto, P., Faletto, D., Delli Castelli, D., Aime, S., & Terreno, E. (2016) The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model. Journal of Controlled Release, 230, 57–63. doi: 10.1016/j.jconrel.2016.03.040.
Ron-Doitch, S., Sawodny, B., Kühbacher, A., David, M. M., Samanta, A., Phopase, J., et al. (2016) Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV. Journal of Controlled Release, 10(229), 163–171. doi: 10.1016/j.jconrel.2016.03.025.
Kulkarni, P. R., Yadav, J. D., & Vaida, K. A. (2011) Liposomes: a novel drug delivery system. International Journal of Current Pharmaceutical Research, 3(2), 32–41.
Li, Y., Liu, R., Yang, J., Shi, Y., Ma, G., Zhang, Z., & Zhang, X. (2015) Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. Biomaterials, 41, 1–14. doi: 10.1016/j.biomaterials.2014.11.010.
Torchilin, V. (2011) Tumor delivery of macromolecular drugs based on the EPR effect. Advanced Drug Delivery Reviews, 63, 131–135. doi: 10.1016/j.addr.2010.03.011.
Stadnichenko, A. V., Krasnopoljskij, Y. M., & Shvets, V. I. (2014) Tekhnologiya polucheniya liposomal'nykh form irinotekana (obzor). [Technology for production of liposomal irinotecan (a review)]. Biofarmacevticheskij zhurnal, 6(6), 3–9. [in Russian].
West-Ward Pharmaceuticals Corp. (2016) Irinotecan prescribing information. Retrieved from: https://www.drugs.com/pro/ irinotecan.html.
Paulіk, A., Grim, J., & Filip, S. (2012) Predictors of Irinotecan toxicity and efficancy in treatment of metastatic colorectal cancer. Acta Medica, 55(4), 153–159. doi: 10.14712/18059694.2015.39.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
